Article

Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study.

University of British Columbia and Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada.
Annals of internal medicine (Impact Factor: 16.1). 02/2007; 146(3):157-66.
Source: PubMed

ABSTRACT Polysomnography (PSG), despite limited availability and high cost, is currently recommended for diagnosis of obstructive sleep apnea and titration of effective continuous positive airway pressure (CPAP).
To test the utility of a diagnostic algorithm in conjunction with ambulatory CPAP titration in initial management of obstructive sleep apnea.
A randomized, controlled, open-label trial that compared standard PSG with ambulatory CPAP titration in high-risk patients identified by a diagnostic algorithm.
A tertiary referral sleep disorders program in Vancouver, British Columbia, Canada.
68 patients with a high pretest probability of moderate to severe obstructive sleep apnea (apnea-hypopnea index [AHI] >15 episodes/h) identified by sequential application of the Epworth Sleepiness Scale (ESS) score, Sleep Apnea Clinical Score, and overnight oximetry.
Patients were randomly assigned to PSG or ambulatory titration by using a combination of auto-CPAP and overnight oximetry. They were observed for 3 months.
Apnea-hypopnea index on CPAP, ESS score, quality of life, and CPAP adherence.
The PSG and ambulatory groups had similar median BMI (38 kg/m2), age (55 years), ESS score (14 points), and respiratory disturbance index (31 episodes of respiratory disturbance/h). Each episode is determined by a computer algorithm based on analysis of oxygen saturation measured by pulse oximetry. After 3 months, there were no differences in the primary outcome, AHI on CPAP (median, 3.2 vs. 2.5; difference, 0.8/h [95% CI, -0.9 to 2.3]) (P = 0.31), between the PSG and ambulatory groups, or in the secondary outcomes, ESS score, Sleep Apnea Quality of Life Index, and CPAP. Adherence to CPAP therapy was better in the ambulatory group than in the PSG group (median, 5.4 vs. 6.0; difference, -1.12 h/night [CI, -2.0 to 0.2]) (P = 0.021).
In the initial management of patients with a high probability of obstructive sleep apnea, PSG confers no advantage over the ambulatory approach in terms of diagnosis and CPAP titration. The ambulatory approach may improve adherence to treatment. When access to PSG is inadequate, the ambulatory approach can be used to expedite management of patients most in need of treatment.

0 Followers
 · 
231 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: La CPAP es el tratamiento de elección en pacientes con SAHS. Los pacientes con un IAH > 5 y síntomas, son susceptibles de tratamiento con CPAP nasal. Si no tienen síntomas, con patología cardiovascular, se debe considerar el tratamiento si el IAH >30, especialmente en pacientes con edad inferior a 70 años. Puesto que no es un tratamiento curativo, debe usarse de forma continuada, y para esto debemos hacer un ajuste de la presión óptima, para la que es imprescindible una adecuada información y preparación del enfermo, pudiendo realizarse diversas técnicas para el ajuste. La PSG completa en el laboratorio de sueño es la que mejor asegura la corrección de todos los fenómenos patológicos (respiratorios y neurológicos). Pero debido a lo costoso y largo del procedimiento y a las largas listas de espera se han propuesto otras opciones como son la PSG en noche partida para pacientes con IAH>20, el ajuste empírico mediante fórmula matemática, que puede usarse de manera provisional, a la espera de titulación, y un sistema de Auto-CPAP validado y con análisis visual (Normativa SEPAR 2010). Uno de los procedimientos más extendidos, para titular la presión de CPAP es el uso de equipos de CPAP automática. Existe una gran diversidad de equipos, con comportamientos diferentes, ya que utilizan un algoritmo de presión diferente, y variables distintas. Sin embargo, en otros estudios clínicos no se han encontrado diferencias. Estos, miden varias variables respiratorias, para detectar anormalidades respiratorias. Básicamente existen 3 variables de medida: flujo, ronquido e impedancia (valorada mediante oscilación forzada). Aunque inicialmente no todos los equipos utilizaban todas las variables, hoy la mayoría utilizan todas ellas con diferentes algoritmos.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives. There are many studies regarding unnecessary polysomnography (PSG) when obstructive sleep apnea syndrome (OSAS) is suspected. In order to reduce unnecessary PSG, this study aims to predict the apnea-hypopnea index (AHI) via simple clinical data for patients who complain of OSAS symptoms. Method. Demographic, anthropometric, physical examination and laboratory data of a total of 390 patients (290 men, average age 50 ± 11) who were subject to diagnostic PSG were obtained and evaluated retrospectively. The relationship between these data and the PSG results was analyzed. A multivariate linear regression analysis was performed step by step to identify independent AHI predictors. Results. Useful parameters were found in this analysis in terms of body mass index (BMI), waist circumference (WC), neck circumference (NC), oxygen saturation measured by pulse oximetry (SpO2), and tonsil size (TS) to predict the AHI. The formula derived from these parameters was the predicted AHI = (0.797 × BMI) + (2.286 × NC) - (1.272 × SpO2) + (5.114 × TS) + (0.314 × WC). Conclusion. This study showed a strong correlation between AHI score and indicators of obesity. This formula, in terms of predicting the AHI for patients who complain about snoring, witnessed apneas, and excessive daytime sleepiness, may be used to predict OSAS prior to PSG and prevent unnecessary PSG.
    International Journal of Otolaryngology 10/2014; 2014:438376. DOI:10.1155/2014/438376
  • [Show abstract] [Hide abstract]
    ABSTRACT: Study Objectives: Compare auto-adjusting positive airway pressure (APAP) treatment with positive airway pressure (PAP) titration by polysomnography (PSG) followed by CPAP treatment in patients diagnosed with obstructive sleep apnea (OSA) by home sleep apnea testing (HSAT). Design: Prospective randomized treatment study. Setting: Tertiary Veterans Administration Medical Center. Participants: 156 patients diagnosed with OSA by HSAT (apneahypopnea index [AHI] >= 10/h) suitable for APAP treatment. Interventions: APAP arm: Treatment with an APAP device, CPAP arm: PSG PAP titration followed by CPAP treatment. Measurements: Mean PAP adherence, Epworth sleepiness scale (ESS), Functional Outcomes of Sleep Questionnaire (FOSQ). Results: The mean (+/- SD) age, BMI, and diagnostic AHI (APAP: 28.6 +/- 18.5, CPAP: 28.3 +/- 16.0/h, p = NS) did not differ between the study arms. After 6 weeks of treatment, 84.6% of 78 patients started on APAP and 84.3% of 70 patients started on CPAP (8 declined treatment after the titration) were using PAP, p = NS. The 90% APAP and level of CPAP were similar (10.8 +/- 3.1, 11.7 +/- 2.5 cm H2O, p = 0.07). The average nightly PAP use did not differ (APAP: 4.45 +/- 2.3, CPAP: 4.0 +/- 2.3 h, p = NS). The improvements in the ESS (APAP: -4.2 +/- 4.7, CPAP: -3.7 +/- 4.8, p = NS) and in the FOSQ (APAP: 2.6 +/- 3.5, CPAP: 2.2 +/- 3.7, p = NS) were not different. Conclusions: Following diagnosis of OSA by HSAT, treatment with APAP results in equivalent PAP adherence and improvement in sleepiness compared to a PSG titration and CPAP treatment.
    Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine 10/2014; 10(12). DOI:10.5664/jcsm.4272 · 2.83 Impact Factor

Preview

Download
10 Downloads